The one thing you can say for Illumina is that its corporate leaders have chutzpah. For those of you who didn’t grow up with grandparents from Eastern Europe, “chutzpah” is the Yiddish word for guts and nerve. Proceeding with the $8.1 billion Grail acquisition without regulatory approval from the European Community (EC) last August took…
Illumina Partners for Development of Next-Gen Sequencing Tests
The one thing you can say for Illumina is that its corporate leaders have chutzpah. For those of you who didn’t grow up with grandparents from Eastern Europe, “chutzpah” is the Yiddish word for guts and nerve. Proceeding with the $8.1 billion Grail acquisition without regulatory approval from the European Community (EC) last August took […]
